With the analysis among 83 patents, we discovered top 55 key players by total patent application. Eli Lilly & Co., Novartis AG, Intercept Pharmaceuticals, Inc. are dominant in this area. They take 14.46% of the total patent filing.
Indiana, United States
Patent: 5
Basel-Stadt, Switzerland
Patent: 4
New York, United States
Patent: 2
California, United States
Patent: 2
New Jersey, United States
Patent: 2
Kansas, United States
Patent: 2
BERKSHIRE, United Kingdom
Patent: 2
Jiangsu Sheng, China
Patent: 2
With the analysis among 5 patents, we discovered top 5 start-ups by total patent application. Nacuity Pharmaceuticals, Inc., Goldfinch Bio, Inc., Invirsa, Inc. are active in this area.
Texas, United States
Patent: 1
Massachusetts, United States
Patent: 1
Ohio, United States
Patent: 1
Shanghai Shi, China
Patent: 1
North Carolina, United States
Patent: 1
With the analysis among related 69 patents applied in the last 5 years. We discover 33 most active companies in this area. The fast-growing Eli Lilly & Co., Insignis Therapeutics, Inc., Intercept Pharmaceuticals, Inc. take 14.49% of patent filing during this period.
Indiana, United States
Patent: 5
undefined undefined
Patent: 3
New York, United States
Patent: 2
Basel-Stadt, Switzerland
Patent: 2
California, United States
Patent: 1
New Jersey, United States
Patent: 1
Massachusetts, United States
Patent: 1
With the analysis among related 69 patents in last 5 years, we discover 31 new entrants. Eli Lilly & Co., Insignis Therapeutics, Inc., Intercept Pharmaceuticals, Inc. are the most active new entrants in this area.
Indiana, United States
Patent: 5
undefined undefined
Patent: 3
New York, United States
Patent: 2
California, United States
Patent: 1
New Jersey, United States
Patent: 1
Massachusetts, United States
Patent: 1
Beijing Institute of Heart Lung & Blood Vessel Diseases
No data, please try another search term